Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence

BACKGROUND: According to the Response Assessment in Neuro-Oncology criteria, new enhancement within the radiation field on contrast enhanced T1-weighted images within 12 weeks after completion of radiotherapy should not qualify for progressive disease, since up to 50% of these cases may be pseudopro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Radbruch, Alexander, Fladt, Joachim, Kickingereder, Philipp, Wiestler, Benedikt, Nowosielski, Martha, Bäumer, Philipp, Schlemmer, Heinz-Peter, Wick, Antje, Heiland, Sabine, Wick, Wolfgang, Bendszus, Martin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2015
Soggetti:
Imaging
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483046/
https://ncbi.nlm.nih.gov/pubmed/25038253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou129
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi